Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
11/29/2006 | EP1725554A1 Hiv integrase inhibitors |
11/29/2006 | EP1725295A2 Compositions and use of tyrosine kinase inhibitors to treat pathogenic infection |
11/29/2006 | EP1725261A2 Use for interleukin-33 (il-33) and the il-33 receptor complex |
11/29/2006 | EP1725102A1 Hiv integrase inhibitors |
11/29/2006 | EP1487467B1 Bioactive hexane fraction from vetiveria zizanioides |
11/29/2006 | EP1480624B1 Pharmaceutical tablet |
11/29/2006 | EP1366080B1 Natural antibodies active against hiv virus |
11/29/2006 | EP1301614B1 Codon-optimized papilloma virus sequences |
11/29/2006 | EP1259223A4 Protein matrix materials, devices and methods of making and using thereof |
11/29/2006 | EP1248650B1 Improved dna vaccines for bovine herpesvirus-1 |
11/29/2006 | EP1220911B1 P-glycoproteins and uses thereof |
11/29/2006 | EP1218403B1 Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery |
11/29/2006 | EP1206529B1 UDP-N-ACETYLGLUCOSAMINE: GALACTOSE-BETA 1,3-N-ACETYLGALACTOSAMINE-ALPHA-R/(GlcNAc to GalNAc) BETA 1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE, C2GnT3 |
11/29/2006 | EP1162999B1 Vaccine against Streptococcus pneumoniae |
11/29/2006 | EP1158993B1 Bacterial membrane fractions with adjuvant effect |
11/29/2006 | EP1079857B1 Combination meningitidis b/c vaccines |
11/29/2006 | EP1068331B1 Medicaments for inducing cytotoxic t-cells |
11/29/2006 | EP1026246B1 Avian infectious herpesvirus recombinants and recombinant vaccines prepared with the use of the same |
11/29/2006 | EP1024792B1 Topical antifungal composition |
11/29/2006 | EP0948624B1 Mutants of streptococcal toxin a and methods of use |
11/29/2006 | EP0719336B1 Modified plant viruses as vectors of heterologous peptides |
11/29/2006 | EP0556292B2 Hepatitis c virus asialoglycoproteins |
11/29/2006 | CN1871250A Nucleoside compounds for treating viral infections |
11/29/2006 | CN1871248A Novel sulfenamide oxides |
11/29/2006 | CN1871247A Novel sulfenamides |
11/29/2006 | CN1871023A A teicoplanin composition with improved antibiotic activity |
11/29/2006 | CN1871012A 7 and 8 membered heterocyclic cyclopentyl benzylamide modulators of chemokine receptor activity |
11/29/2006 | CN1869243A Recombined porcine adenovirus based viral vaccines and vectors |
11/29/2006 | CN1869237A Construction method of bismall molecule interference RNA carrier and its application |
11/29/2006 | CN1869210A Purification method of human glutathione-s-transferase Pi and application of said enzyme |
11/29/2006 | CN1869069A Recombination enterovirus 71 type neutralization antibudy and its use |
11/29/2006 | CN1869061A Peptidomimetic protease inhibitors |
11/29/2006 | CN1869027A Synthesis and antiprotozoal activity of dicationic 3,5-diphenylisoxazoles |
11/29/2006 | CN1868553A Cervical skin tissue engineering stent and its making method |
11/29/2006 | CN1868545A Improved vaccines |
11/29/2006 | CN1868534A Medicine composition, its prepn. method, quality control method |
11/29/2006 | CN1868524A Shengmai dripping pills and its preparing method |
11/29/2006 | CN1868504A Method for preparing Weigan Futai capsule for treating liver complaint |
11/29/2006 | CN1868503A Extractive of Herba Rabdosiae diterpene, its prepn. method and its medicine composition |
11/29/2006 | CN1868501A Compound isatic root oral liquor prepn. and its prepn. method |
11/29/2006 | CN1868494A Vinegar with function of treating barbier |
11/29/2006 | CN1868478A Compound prepn. injection contg. cefoperazone sodium and tazobactam sodium |
11/29/2006 | CN1868470A Abiduoer granular formulation |
11/29/2006 | CN1868465A Application of anthraquinone derivatives (emodin) for pharmacy |
11/29/2006 | CN1868460A Doxycycline hydrochloride freeze-dried power prepn. for injection, and process for preparing same |
11/29/2006 | CN1868451A Injection prepn. contg. cardxacin, and its prepn. method |
11/29/2006 | CN1868449A Ganciclovir ophthalmic gel and its prepn. method |
11/29/2006 | CN1286845C Nucleosides analogues, such as antivirals including inhibitors of retroviral reverse transcriptase and the dna polymerase of hepatitis b virus (HBV) |
11/29/2006 | CN1286841C Production method of rifampicin isomer, rifampicin derivative and its mixture |
11/29/2006 | CN1286835C Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents |
11/29/2006 | CN1286529C Skin targeting medicinal composition and its preparation and use |
11/29/2006 | CN1286525C New type pellicle of ocean lysozyme and preparation method |
11/29/2006 | CN1286487C Plaster for treating mumps |
11/29/2006 | CN1286484C Medicinal preparation for treating cold |
11/29/2006 | CN1286483C Chinese traditional drug pills capable of protecting liver, resisting hepatic fibrosis and expelling toxins |
11/29/2006 | CN1286473C Chinese medicinal preparation with viral infection resisting function |
11/29/2006 | CN1286469C Pharmaceutical use of isolarisiresinol |
11/29/2006 | CN1286467C Method for producing antibiotic preparation and its application |
11/29/2006 | CN1286465C Radix salviae miltiorrhizae oligosaccharide and its application for resisting acquired immunodeficiency syndrome, adjusting immunity and increasing leukocyte |
11/29/2006 | CN1286463C Dry cow mamma perfusion agent for preventing and curing cow mastitis and preparation method thereof |
11/29/2006 | CN1286460C Application of sophocarpine on preparing medication for curing disease caused by coronavirus |
11/29/2006 | CN1286459C Transparent and disappearing external medicine preparation containing benzotolazo |
11/29/2006 | CN1286457C Freeze-dried powder injection of andrographolide and preparation thereof |
11/29/2006 | CN1286455C Pharmaceutical use of 5-hydroxymethyl furfural |
11/29/2006 | CN1286452C Chicken gallbladder extractum dispersible tablet and its preparation process |
11/28/2006 | US7141660 Genes encoding a nystatin polyketide synthase and their manipulation and utility |
11/28/2006 | US7141658 Nucleotide sequences in the rpoB gene of spirochetes code for the beta subunit of the bacterial RNA polymerase; amplification, sequencing and comparison; complexing with genetic probes |
11/28/2006 | US7141651 Multiple cytokine protein complexes |
11/28/2006 | US7141599 Immunosuppressive effects of administration of a cyclooxygenase-2 inhibitor, a leukotriene B4 receptor inhibitor and a cyclosporin |
11/28/2006 | US7141583 Activity against both Gram-positive and Gram-negative pathogens are generally regarded as having a broad spectrum of activity |
11/28/2006 | US7141580 activity as prostaglandin E2 receptor antagonists |
11/28/2006 | US7141574 Viral polymerase inhibitors |
11/28/2006 | US7141572 For therapy of osteoporosis, tumours, cachexia, atherosclerosis, rheumatoid arthritis, multiple sclerosis, diabetes mellitus, inflammatory processes, allergies, asthma, autoimmune diseases, myocardial diseases and AIDS |
11/28/2006 | US7141569 Antiviral pyrazolopyridine compounds |
11/28/2006 | US7141564 are active against a wide range of organisms including both Gram-negative and Gram-positive organisms |
11/28/2006 | US7141557 Lipid analogs for treating viral infections |
11/28/2006 | US7141554 Method of treating irritable bowel syndrome |
11/28/2006 | US7141550 Intra-tumoral administration of IL-12 encoding nucleic acid molecules |
11/28/2006 | US7141520 Antimicrobial alkali-silicate glass ceramic and the use thereof |
11/28/2006 | US7141418 Computer readable medium having recorded thereon given nucleotide sequence; use in identifying commercially important nucleic acid fragments |
11/28/2006 | US7141408 live vector vaccine; removal of sole dependence on catalytic balanced lethal maintenance systems; plasmid partition system prevents random segregation; enhanced inheritance and stability; genetic engineering; antibiotic resistance |
11/28/2006 | US7141251 Pharmacologically active strong acid solutions |
11/28/2006 | US7141243 gM-negative EHV-mutants without heterologous elements |
11/28/2006 | CA2379786C Purine derivatives |
11/28/2006 | CA2375524C 3-(arylsulfonylamino)-tetrahydropyran-3-carboxylic acid hydroxamides |
11/28/2006 | CA2375513C 3-(arylsulfonylamino)-tetrahydrofuran-3-carboxylic acid hydroxamides |
11/28/2006 | CA2256514C Veterinary use of a pleuromutilin derivative |
11/28/2006 | CA2200409C Bis alkanoyl esters of carnitine having bactericidal, fungicidal and antiprotozoal activity |
11/28/2006 | CA2167525C Fungicidal methods and compositions for killing yeast and sporular microorganisms |
11/23/2006 | WO2006125121A2 Antimicrobial composition comprising a cationic surfacant and an iodinated sulpone compound |
11/23/2006 | WO2006124753A2 Antipyretic agents against vr1-antagonist-induced increases in body temperature |
11/23/2006 | WO2006123953A1 Inhibitors of nucleoside phosphorylases and nucleosidases |
11/23/2006 | WO2006123792A1 Tri- or tetra-substituted-3-aminopyrrolidine derivatives |
11/23/2006 | WO2006123767A1 Method for producing asymmetric tetrasubstituted carbon atom-containing compound |
11/23/2006 | WO2006123639A1 Pyrimidine derivative |
11/23/2006 | WO2006123145A1 Antifungal agents |
11/23/2006 | WO2006122986A2 Use of penicillin-binding proteins or polynucleotides or antibodies thereof for preventing or treating bacterial infections |
11/23/2006 | WO2006122716A1 Use of ether-linked lysophosphatidylcholines and alkylphosphocholines for the treatment of papilloma virus induced warts and sarcoids |
11/23/2006 | WO2006122409A1 Antimicrobial molecules and their uses |
11/23/2006 | WO2006122404A1 Trappin-2 (elafin) inhibits hiv |